Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (151-160 of 241) with videos related to

Pageof 25
Sort By:
Haematologica|May 13, 2014
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipientsLori S Muffly, Masha Kocherginsky, Wendy Stock, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2006
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantationAndrew S Artz, Daniel A Pollyea, Masha Kocherginsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2019
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant RecipientsWesley S Rogers, Lars F Westblade, Rosemary Soave, et al.
Haematologica|September 2, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomesKoen van Besien, Jeanette Carreras, Philip J Bierman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two PracticesAmrita D Singh, Sapna Parmar, Khilna Patel, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Haematologica|February 9, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Oncoimmunology|June 23, 2017
Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplantSami B Kanaan, Hilary S Gammill, Whitney E Harrington, et al.
Bone Marrow Transplantation|December 1, 2020
Cord blood maternal microchimerism following unrelated cord blood transplantationSami B Kanaan, Colleen Delaney, Filippo Milano, et al.
Pageof 25

Showing results (151-160 of 241) with videos related to

Sort By:
Pageof 25
Haematologica|May 13, 2014
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipientsLori S Muffly, Masha Kocherginsky, Wendy Stock, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2006
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantationAndrew S Artz, Daniel A Pollyea, Masha Kocherginsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2019
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant RecipientsWesley S Rogers, Lars F Westblade, Rosemary Soave, et al.
Haematologica|September 2, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomesKoen van Besien, Jeanette Carreras, Philip J Bierman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two PracticesAmrita D Singh, Sapna Parmar, Khilna Patel, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Haematologica|February 9, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Oncoimmunology|June 23, 2017
Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplantSami B Kanaan, Hilary S Gammill, Whitney E Harrington, et al.
Bone Marrow Transplantation|December 1, 2020
Cord blood maternal microchimerism following unrelated cord blood transplantationSami B Kanaan, Colleen Delaney, Filippo Milano, et al.
Pageof 25